Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V I Leussink

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Der Nervenarzt|November 25, 2010
[Interferon β for multiple sclerosis. How much is good enough?]C Warnke, V I Leussink, B C Kieseier, et al.
Journal of Neurology|June 5, 2016
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational studyA Miclea, V I Leussink, H P Hartung, et al.
Der Nervenarzt|April 3, 2015
[Pegylated interferon beta 1a. A new therapy option for treatment of relapsing-remitting multiple sclerosis]V I Leussink, C Warnke, B Tackenberg, et al.
Der Nervenarzt|January 30, 2010
[4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis]L Husseini, V I Leussink, B C Kieseier, et al.
Der Nervenarzt|November 15, 2011
[Cannabinoids for symptomatic therapy of multiple sclerosis]L Husseini, V I Leussink, C Warnke, et al.
Archives of Neurology|February 15, 2001
High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytesV I Leussink, S Jung, U Merschdorf, et al.
European Journal of Neurology|January 30, 2009
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosisT Kopadze, M Döbert, V I Leussink, et al.
Acta Neurologica Scandinavica|January 25, 2003
Superficial siderosis of the central nervous system: pathogenetic heterogeneity and therapeutic approachesV I Leussink, P Flachenecker, D Brechtelsbauer, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 8, 2014
Monomethylfumarate reduces in vitro migration of mononuclear cellsT Dehmel, M Döbert, S Pankratz, et al.
Acta Neuropathologica|January 26, 2002
Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritisV I Leussink, U K Zettl, S Jander, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Der Nervenarzt|November 25, 2010
[Interferon β for multiple sclerosis. How much is good enough?]C Warnke, V I Leussink, B C Kieseier, et al.
Journal of Neurology|June 5, 2016
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational studyA Miclea, V I Leussink, H P Hartung, et al.
Der Nervenarzt|April 3, 2015
[Pegylated interferon beta 1a. A new therapy option for treatment of relapsing-remitting multiple sclerosis]V I Leussink, C Warnke, B Tackenberg, et al.
Der Nervenarzt|January 30, 2010
[4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis]L Husseini, V I Leussink, B C Kieseier, et al.
Der Nervenarzt|November 15, 2011
[Cannabinoids for symptomatic therapy of multiple sclerosis]L Husseini, V I Leussink, C Warnke, et al.
Archives of Neurology|February 15, 2001
High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytesV I Leussink, S Jung, U Merschdorf, et al.
European Journal of Neurology|January 30, 2009
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosisT Kopadze, M Döbert, V I Leussink, et al.
Acta Neurologica Scandinavica|January 25, 2003
Superficial siderosis of the central nervous system: pathogenetic heterogeneity and therapeutic approachesV I Leussink, P Flachenecker, D Brechtelsbauer, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 8, 2014
Monomethylfumarate reduces in vitro migration of mononuclear cellsT Dehmel, M Döbert, S Pankratz, et al.
Acta Neuropathologica|January 26, 2002
Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritisV I Leussink, U K Zettl, S Jander, et al.
Pageof 1